{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:48:43Z","timestamp":1790473723261,"version":"4.1.0"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2020,6,19]]},"abstract":"<jats:sec><jats:title>Objective:<\/jats:title><jats:p>A basic, powerful and isocratic chiral fluid chromatographic technique was created and approved for the enantiomeric partition of meclizine hydrochloride in pharmaceutical dose structure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The chromatographic partition was accomplished on Phenomenex\u00ae Lux Cellulose 1 (250 mm x 4.6 mm i.d, 5 \u03bcm molecule size) section utilizing portable stage framework containing acetonitrile: 25mM ammonium bicarbonate (75:25%v \/v). The versatile stage was siphoned on the segment at the stream pace of 1.0 mL\/min, and UV recognition was done at 230 nm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Result:<\/jats:title><jats:p>The breaking points of recognition and measurement were observed to be 0.25 \u03bcg\/mL and 1.00 \u03bcg\/mL individually, for 20\u03bcL infusion volume. The alignment bend demonstrated phenomenal linearity over the focus scope of 1-5 \u03bcg\/mL for (\u00b1) meclizine enantiomers with a relationship coefficient (r2 = 0.999). The recuperation investigation of meclizine from tablet plan was observed to be 97.33% and 98.81% separately. Meclizine standard arrangement and versatile stage were observed to be steady for in any event 32h. The meclizine enantiomers were very much settled with mean maintenance times of about (+) Meclizine at 13.14 min and (-) Meclizine at 14.33 min individually.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>The created technique was broadly approved and demonstrated to be hearty, exact, exact and appropriate for the examination of meclizine enantiomers in tablet measurement structure and security investigations of meclizine.<\/jats:p><\/jats:sec>","DOI":"10.2174\/2589977511666191211123337","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T09:38:01Z","timestamp":1576661881000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Enantiomeric Separation of Meclizine Hydrochloride in Pharmaceutical Dosage Form by HPLC Method"],"prefix":"10.2174","volume":"12","author":[{"given":"Byran","family":"Gowramma","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, (JSS Academy of Higher Education and Research), Udhagamandalam, Nilgiris-643001, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran Senthil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, JSS College of Pharmacy, (JSS Academy of Higher Education and Research), Udhagamandalam, Nilgiris-643001, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajagopal","family":"Kalirajan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, (JSS Academy of Higher Education and Research), Udhagamandalam, Nilgiris-643001, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaviarasan","family":"Lakshmanan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, JSS College of Pharmacy, (JSS Academy of Higher Education and Research), Udhagamandalam, Nilgiris-643001, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramanian Nainar","family":"Meyyanathan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Analysis, JSS College of Pharmacy, (JSS Academy of Higher Education and Research), Udhagamandalam, Nilgiris-643001, Tamilnadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1351\/pac199163081119","volume":"63","author":"Willium H.","year":"1991","unstructured":"Willium H.; Porter. Resolution of chiral drugs. Pure Appl Chem 1991,63(8),1119-1122","journal-title":"Pure Appl Chem"},{"key":"ref=2","first-page":"446","volume":"35","author":"Valliappan K.","year":"1998","unstructured":"Valliappan K.; Molecular handedness: Impact on the development of chiral drugs. Indian Drugs 1998,35(7),446-457","journal-title":"Indian Drugs"},{"key":"ref=3","first-page":"277","volume":"39","author":"Valliappan K.","year":"2002","unstructured":"Valliappan K.; Kannan K.; Manavalan R.; Muralidharan C.; Selection of chromatographic technique (HPLC\/HPTLC) for chiral analysis using analytical hierarchy process. Indian J Pharm Sci 2002,39(5),277-288","journal-title":"Indian J Pharm Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4088\/PCC.v05n0202","volume":"5","author":"McConathy J.","year":"2003","unstructured":"McConathy J.; Owens M.J.; Owens. Stereochemistry in drug action. prim care companion. J Clin Psychiatry 2003,5(2),70-73","journal-title":"J Clin Psychiatry"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","volume":"2","author":"Nguyen L.A.","year":"2006","unstructured":"Nguyen L.A.; He H.; Pham-Huy C.; Chiral drugs: An overview. Int J Biomed Sci 2006,2(2),85-100","journal-title":"Int J Biomed Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1573411052948433","volume":"1","author":"Bojarski J.","year":"2005","unstructured":"Bojarski J.; Hassan Y.; Aboul Enein, Ashraf Ghanem. What\u2019s new in chromatographic enantio separations. Curr Anal Chem 2005,1,59-77","journal-title":"Curr Anal Chem"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S0378-4347(98)00246-1","volume":"717","author":"Arai T.","year":"1998","unstructured":"Arai T.; Chiral separation of pharmaceuticals possessing a carboxy moiety. J Chromatogr B Biomed Sci Appl 1998,717(1-2),295-311","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9673(01)91766-2","volume":"426","author":"Mehta A.C.","year":"1988","unstructured":"Mehta A.C.; Direct separation of drug enantiomers by high-performance liquid chromatography with chiral stationary phases. J Chromatogr A 1988,426(1),1-13","journal-title":"J Chromatogr A"},{"key":"ref=9","first-page":"273","volume":"67","author":"Valliappan K.","year":"2005","unstructured":"Valliappan K.; Reflections on chiral chromatographic analysis. Indian J Pharm Sci 2005,67(3),273-282","journal-title":"Indian J Pharm Sci"},{"key":"ref=10","first-page":"117","volume":"5","author":"Sethi PD","year":"2001","unstructured":"Sethi PD; High performance liquid chromatography. 1 New Delhi 2001,5(59),117-151","journal-title":"1 New Delhi"},{"key":"ref=11","first-page":"1","author":"Kiyokatsu J.","year":"1997","unstructured":"Kiyokatsu J.; Chromatographic separations based on molecular recognition 1997,1-66","journal-title":"Chromatographic separations based on molecular recognition"},{"key":"ref=12","first-page":"1","author":"Marvin C.","year":"2005","unstructured":"Marvin C.; McMaster LC\/MS A practical user\u2019s guide 2005,1-58","journal-title":"McMaster LC\/MS A practical user\u2019s guide"},{"key":"ref=13","first-page":"48","volume":"26","author":"Reynolds D.W.","year":"2002","unstructured":"Reynolds D.W.; Facchine K.L.; Mullaney J.F.; Alsante K.M.; Hatajik T.D.; Motto M.G.; Available guidance and best practices for conducting forced degradation studies. Pharm Technol 2002,26(2),48-56","journal-title":"Pharm Technol"},{"key":"ref=14","first-page":"56","volume":"7","author":"Reynolds D.W.","year":"2004","unstructured":"Reynolds D.W.; Forced degradation of pharmaceuticals. Acta Pharm 2004,7(3),56-61","journal-title":"Acta Pharm"},{"key":"ref=15","first-page":"98","volume":"25","author":"Thatcher S.R.","year":"2001","unstructured":"Thatcher S.R.; Mansfield R.K.; Miller R.B.; Davis C.W.; Baertschi S.W.; Pharmaceutical photostability. Pharm Technol 2001,25(3),98-110","journal-title":"Pharm Technol"},{"key":"ref=16","first-page":"7","volume":"18","author":"Kats M.","year":"2005","unstructured":"Kats M.; Forced degradation studies: Regulatory considerations and implementation. Biopharm Int 2005,18,7","journal-title":"Biopharm Int"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.addr.2006.10.006","volume":"59","author":"Alsante K.M.","year":"2007","unstructured":"Alsante K.M.; Ando A.; Brown R.; The role of degradant profiling in active pharmaceutical ingredients and drug products. Adv Drug Deliv Rev 2007,59(1),29-37","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=18","unstructured":"Text on validation of analytical procedures international conference on harmonization ICH. Q2A.","journal-title":"Text on validation of analytical procedures international conference on harmonization"},{"key":"ref=19","unstructured":"Q3B validation of analytical procedures: J Pharm Biomed Anal ICH","journal-title":"J Pharm Biomed Anal"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/chromsci\/bmu127","volume":"53","author":"Peraman R.","year":"2015","unstructured":"Peraman R.; Manikala M.; Kondreddy V.K.; Yiragamreddy P.R.; A stability-indicating RP-HPLC method for the quantitative analysis of meclizine hydrochloride in tablet dosage form. J Chromatogr Sci 2015,53(5),793-799","journal-title":"J Chromatogr Sci"},{"key":"ref=21","first-page":"29","volume":"5","author":"Naveen K.G.S.","year":"2017","unstructured":"Naveen K.G.S.; Srinivas U.; Joshi H.; Development and validation of spectrophotometric method for simultaneous estimation of meclizine and folic acid in bulk and pharmaceutical dosage forms. Pharma Tutor 2017,5(6),29-34","journal-title":"Pharma Tutor"},{"key":"ref=22","first-page":"667","volume":"7","author":"Ashwini D.","year":"2018","unstructured":"Ashwini D.; Pote, Kalyani B. Wagh, Sachin G. Dhandore, Rajendra Khedkar. Development of HPLC method for meclizine hydrochloride by using quality by design approach. World J Pharm Pharm Sci 2018,7(8),667-686","journal-title":"World J Pharm Pharm Sci"},{"key":"ref=23","first-page":"296","volume":"4","year":"2014","unstructured":"Vinod kumar K, Sudhakar M, Padmanabha Redd Y, Sudheer Reddy M, Lavanya M. RP-HPLC method development and validation for simultaneous estimation of meclizine hydrochloride and nicotinic acid in pharmaceutical dosage form and in plasma Indo american. Pharmacol Res 2014,4(6),296-675","journal-title":"Pharmacol Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1023\/A:1024891618953","volume":"18","author":"K\u00e4ll\u00e9n B.","year":"2003","unstructured":"K\u00e4ll\u00e9n B.; Mottet I.; Delivery outcome after the use of meclozine in early pregnancy. Eur J Epidemiol 2003,18(7),665-669","journal-title":"Eur J Epidemiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/BF00169830","volume":"349","author":"Oishi R.","year":"1994","unstructured":"Oishi R.; Shishido S.; Yamori M.; Saeki K.; Comparison of the effects of eleven histamine H1-receptor antagonists on monoamine turnover in the mouse brain. Naunyn Schmiedebergs Arch Pharmacol 1994,349(2),140-144","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref=26","first-page":"857","volume":"5","author":"Shinde P.","year":"2012","unstructured":"Shinde P.; Rai C.; Daswadhar S.; Pallavi C.; Kasture P.V.; Development of UV spectrophotometric method of meclizine hydrochloride in bulk and pharmaceutical formulation. Res J Pharm Technol 2012,5(6),857-859","journal-title":"Res J Pharm Technol"},{"key":"ref=27","first-page":"1249","volume":"4","author":"Ravalji M.B.","year":"2011","unstructured":"Ravalji M.B.; Shah S.A.; Shah D.R.; Daxina K.L.; Chauhan R.S.; Spectroscopic methods for simultaneous estimation of meclizine hydrochloride and caffeine in their combined tablet dosage form. Asian J Res Chem 2011,4,1249-1253","journal-title":"Asian J Res Chem"},{"key":"ref=28","author":"Ramakanth Reddy D.","year":"2013","unstructured":"Ramakanth Reddy D.; Padmanabha Reddy P.; Devanna N.; Amaranatha Reddy B.; A new validated RP-HPLC-DAD method for simultaneous determination of meclizine and caffeine pharmaceutical dosage form. J Pharm Sci 2013","journal-title":"J Pharm Sci"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T20:28:57Z","timestamp":1722198537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177354\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6,19]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/2589977511666191211123337","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,19]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}